Description
The “K75 Therapeutically Actionable Panel” is a blood test that analyzes various genes and biomarkers in a patient’s blood sample to identify potential therapeutic targets for cancer treatment. It helps determine if a patient’s cancer has specific genetic mutations that can be targeted by existing or emerging therapies, potentially guiding personalized treatment plans.
Reviews
There are no reviews yet.